|
Volumn 156, Issue 2, 1996, Pages 363-367
|
Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment
a a a a a a a a a a a a a a a
a
NONE
|
Author keywords
Biological; Immunoassay; carcinoma; Transitional cell; bladder neoplasms; tumor markers
|
Indexed keywords
NUCLEAR MATRIX PROTEIN 22;
NUCLEAR PROTEIN;
TUMOR MARKER;
ANALYTICAL EQUIPMENT;
ARTICLE;
BLADDER TUMOR;
CLINICAL TRIAL;
CONFIDENCE INTERVAL;
CYSTOSCOPY;
FOLLOW UP;
HUMAN;
PREDICTION AND FORECASTING;
REPRODUCIBILITY;
ROC CURVE;
SENSITIVITY AND SPECIFICITY;
TIME;
TRANSITIONAL CELL CARCINOMA;
TUMOR RECURRENCE;
URINE;
CARCINOMA, TRANSITIONAL CELL;
CONFIDENCE INTERVALS;
CYSTOSCOPY;
FOLLOW-UP STUDIES;
HUMANS;
NEOPLASM RECURRENCE, LOCAL;
NUCLEAR PROTEINS;
PREDICTIVE VALUE OF TESTS;
REAGENT KITS, DIAGNOSTIC;
REPRODUCIBILITY OF RESULTS;
ROC CURVE;
SENSITIVITY AND SPECIFICITY;
TIME FACTORS;
TUMOR MARKERS, BIOLOGICAL;
URINARY BLADDER NEOPLASMS;
|
EID: 0030213562
PISSN: 00225347
EISSN: None
Source Type: Journal
DOI: 10.1016/S0022-5347(01)65851-8 Document Type: Article |
Times cited : (306)
|
References (10)
|